Cargando…

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy

Patients with prostate cancer (PCa) on androgen-deprivation therapy (ADT) are at high risk of osteoporosis and fragility fractures. We aimed to provide some practical insights into the delivery of optimal bone health care for PCa patients, particularly those on ADT. An interdisciplinary group of exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casado, Enrique, Borque-Fernando, Angel, Caamaño, Manuel, Graña, Jenaro, Muñoz-Rodríguez, Jesús, Morote, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Sexual Medicine and Andrology 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761232/ https://www.ncbi.nlm.nih.gov/pubmed/34983087 http://dx.doi.org/10.5534/wjmh.210061

Ejemplares similares

Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive Model
por: Borque-Fernando, Ángel, et al.
Publicado: (2023)

Guidelines for the management of osteoporosis and fragility fractures
por: Nuti, Ranuccio, et al.
Publicado: (2018)

Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children
por: Galindo-Zavala, Rocío, et al.
Publicado: (2020)

Multidisciplinary expert consensus on secondary fracture prevention in Spain
por: Casado, E., et al.
Publicado: (2021)

Spanish consensus on treat to target for osteoporosis
por: Nogués, X., et al.
Publicado: (2017)

Osteoporosis and Fragility Fractures in Type 2 Diabetes
por: Chiodini, Iacopo, et al.
Publicado: (2020)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
por: Johnson, Matthew E., et al.
Publicado: (2012)

Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach
por: Alito, Angelo, et al.
Publicado: (2023)

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

Clinical aspects and management of osteoporosis and fragility fractures in patients with diabetes
por: Chandran, Manju
Publicado: (2017)

Digital health interventions for osteoporosis and post-fragility fracture care
por: Gupta, Amit, et al.
Publicado: (2022)

A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012)

Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2020)

Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
por: Liao, Kuang-Ming, et al.
Publicado: (2019)

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
por: Shore, Richard, et al.
Publicado: (2021)

The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer
por: Al-Shamsi, Humaid O., et al.
Publicado: (2012)

Clinical Risk Factors for Osteoporotic Fractures in Men With Non-Metastatic Prostate Cancer on Androgen Deprivation Therapy With or Without Anti-Osteoporosis Treatment
por: Sonnabend, Hajerah, et al.
Publicado: (2021)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder
por: Chung, Shiu-Dong, et al.
Publicado: (2017)

Physical Activity as a Strategy to Reduce the Risk of Osteoporosis and Fragility Fractures
por: Karl Karlsson, Magnus, et al.
Publicado: (2012)

Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus
por: Carli, L, et al.
Publicado: (2016)

Are we closing the gaps in the management of osteoporosis following fragility fractures of the femur?
por: Sadat-Ali, Mir, et al.
Publicado: (2019)

Quality and Content of Internet-Based Information for Osteoporosis and Fragility Fracture Diagnoses
por: Wally, Meghan K., et al.
Publicado: (2021)

Evaluation of an Osteoporosis Outreach Program for Men With a Fragility Fracture and Their Physicians
por: Pasquale, Margaret K., et al.
Publicado: (2021)

Corrigendum to “The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer”
por: Al-Shamsi, Humaid O., et al.
Publicado: (2017)

Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells
por: Burton, Dominick G. A., et al.
Publicado: (2013)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Multidisciplinary consensus on cancer management during pregnancy
por: Cubillo, A., et al.
Publicado: (2020)

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
por: Wang, Yanqing, et al.
Publicado: (2016)

Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
por: Hirata, Yu, et al.
Publicado: (2019)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Do patients perceive a link between a fragility fracture and osteoporosis?
por: Giangregorio, Lora, et al.
Publicado: (2008)

Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review
por: Raybould, Grace, et al.
Publicado: (2018)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
por: Ciubean, Alina Deniza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6d6nteebecndjee2hmf1qfe5pv